Hudson Bay Capital Management »

Igm Biosciences shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Igm Biosciences (IGMS) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Igm Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Igm Biosciences held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Igm Biosciences by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 124k 8.31
2023-09-30 $1.0M 124k 8.35

More positions owned by Hudson Bay Capital Management

Amazon Call Option (AMZN)
Microsoft Corporation Put Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Meta Platforms Cl A Put Option (META)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
NVIDIA Corporation Put Option (NVDA)
salesforce Put Option (CRM)
Select Sector Spdr Tr Financial (XLF)
Adobe Systems Incorporated Put Option (ADBE)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Igm Biosciences

Baker Bros. Advisors
T. Rowe Price Associates
Artal Group
Redmile Group
Goldman Sachs Group
RA Capital Management
Vanguard Group
Millennium Management
Citadel Advisors
Samsara BioCapital
Exome Asset Management
Hudson Bay Capital Management
Charles Schwab Investment Management
TD Asset Management
Bruce & Co

View all funds holding Igm Biosciences